Europe

Wed
26
May

As travel restrictions ease, this European city wants to ban cannabis tourism

As more and more people get vaccinated, travel climbs higher onto people’s priority lists. And for cannabis consumers, there’s one particular European destination that likely tops the list.

Fri
21
May

The European Union Is Quickly Becoming A Major Growth Engine For Global Cannabis Companies

During the last year, we have highlighted the cannabis opportunity in the European Union (EU) and have stressed the importance of being levered to this market for companies, especially Canadian Licensed Producers (LPs). 

One of the most significant developments of the year was the closing of the merger of Aphria and Tilray, Inc. (Nasdaq: TLRY) (TSX: TLRY). We believe the EU cannabis market played a key role in the decision to merge and will monitor how this aspect of the story advances from here. We are of the opinion that the combined company is well positioned to benefit from having an early mover advantage in several strategic markets in the EU. 

Thu
20
May

Regulating Cannabinoids One At A Time: Scientific Approach or Delay Tactic?

Here is the good news when it comes to issue of regulating cannabinoids. Last month, the European Commission added Cannabigerol (CBG) to the Cosing List—namely the regional database of allowable ingredients in cosmetics. This after adding natural CBD as an approved substance the month before.

Wed
19
May

Can you travel to Europe with cannabis? 3 things to know before you try flying high

With much of the country vaccinated and summer around the corner, it might finally be time to dust off some of those vacation days you’ve been hoarding. After a year of travel bans and border closures, the European Union has announced that all vaccinated Americans will soon be able to travel freely to and from Europe – which is usually the most popular destination for international travel from the U.S.

Fri
14
May

Access to medicinal cannabis treatments in Europe

In this article, Sita Schubert, General Secretary of the European Medicinal Cannabis Association, discusses the need to get better access to medicinal cannabis treatments to patients in Europe.

Currently, only around one in 300,000 patients in Europe is able to access any kind of medicinal cannabis treatment. The cannabis plant has a lot of medical benefits – there is no doubt about that anymore. One recent study, which collected and assessed patient data over a period of three years, found that cannabis was the most successful treatment available for pain, spasticity, and anorexia.

Tue
04
May

EU’s biggest hemp producer sees profits grow 616 per cent in 2020

HempFlax saw its profits before tax skyrocket 616 per cent in 2020 to €659,000, as demand grew for its construction materials and CBD.

The EU’s biggest hemp grower, headquartered in Holland, saw full year revenues up 43 per cent to €14.5m in 2020, with EBITDA increasing 63 per cent to €1.8m.

The numbers were in part driven by a 1,089 per cent increase in sales of the group’s construction materials, arising from its May 2020 acquisition of Thermo Natur, a German manufacturer of nature fibre insulation.

The group also saw a 43 per cent increase in sales of CBD – a compound found in hemp that is legal for consumption, and often used for pain relief or relief from anxiety or depression.

Thu
22
Apr

Cannabis capitals of Europe: Where has weed been decriminalised on the continent?

There are several locations across Europe where cannabis use is as much part of the culture as French wine and Italian coffee.

In recent years, we’ve seen a huge increase in weed - otherwise known as cannabis or marijuana - becoming legalised for medical use across the board. CBD oil and hemp especially have seen a rise in popularity across markets from skincare to wellness.

While elements of cannabis have their advantages, the science doesn’t work in recreational joint-smokers’ favour. The drug is heavily associated with mental and physical health conditions including psychosis and schizophrenia.

Thu
01
Apr

Changing European hemp policy

Lorenza Romanese, Managing Director of the European Industrial Hemp Association, speaks with HEQ about the benefits of hemp and its derivatives and the need for further policy change.

In early February, the European Commission announced that it had added CBD, which is naturally derived from the hemp plant to CosIng (cosmetic ingredients), to its list of approved cosmetic ingredients. This was the latest step in a series of international moves indicating growing acceptance of the drug, following a ruling by the European Court of Justice in November that CBD is ‘not a narcotic’ and a December vote by the United Nations to remove cannabis from its Schedule 1 list of dangerous drugs.

Tue
30
Mar

Cannabis in Greece: The Nevada of Europe?

A new draft law currently on the desk of the Ministry of Development and Investment is likely to change the equation in not only Greece itself on the cannabis question, but the rest of Europe.

Mon
29
Mar

Hexo Stock: Should Investors Buy As This Cannabis Player Expands Into Europe?

marijuana plants

Canadian legalization of cannabis has resulted in an absolute boom in pot stocks in recent years. Indeed, this past year has been no different. Canadian-listed cannabis stocks have more than doubled from March 2020 lows.

That’s a great thing for cannabis investors looking for a move with tonnes of upside. However, some analysts believe these moves have resulted in cannabis valuations getting ahead of their valuations right now.

Pages

Subscribe to RSS - Europe